Positron emission tomography for molecular imaging of prostate cancer - Abstract

Prostate cancer is the most common malignancy in the urinary system of males.

The remarkable biological and clinical heterogeneity of prostate cancer poses challenges to the initial diagnosis, differential diagnosis, treatment, and prognosis of the disease. Positron emission tomography/computed tomography (PET/CT) is an ideal imaging tool for noninvasive interrogation of underlying tumor biology. Recently, there are a variety of molecular imaging paths and radiopharmaceuticals for the diagnosis and treatment of prostate cancer. This article reviews the current state and prospects of the application of PET in the diagnosis of prostate cancer.

Written by:
Shen GH, Zhang WJ, Jia ZY, Deng HF.   Are you the author?

Reference: Zhonghua Nan Ke Xue. 2014 Nov;20(11):1039-42.

 
PubMed Abstract
PMID: 25577843

Article in Chinese.

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe